BioJapan 2023
This event consists of three exhibitions consisting of the biotechnology exhibition 'BioJapan', 'Regenerative Medicine Japan' which aims to accelerate and industrialise R&D in the field of regenerative medicine including iPS cells and 'Health Tech Japan' providing a fusion of digital technology and life science.
This event consists of three exhibitions consisting of the biotechnology exhibition 'BioJapan', 'Regenerative Medicine Japan' which aims to accelerate and industrialise R&D in the field of regenerative medicine including iPS cells and 'Health Tech Japan' providing a fusion of digital technology and life science.
Meet Kam Dhaliwal, Senior VP Business Development & Alliance Management to discuss how bit.bio offers partnering opportunities that affords access to the most relevant parental human cell types and corresponding disease models. These models are physiologically relevant and highly characterised, offering predictive, in vitro, human cells for early drug discovery, phenotypic screening, and high-content imaging applications.
Click on the button below to arrange a meeting with Kam.
Arrange a meeting